1. Home
  2. VVOS vs BOF Comparison

VVOS vs BOF Comparison

Compare VVOS & BOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVOS
  • BOF
  • Stock Information
  • Founded
  • VVOS 2016
  • BOF 2017
  • Country
  • VVOS United States
  • BOF United States
  • Employees
  • VVOS N/A
  • BOF N/A
  • Industry
  • VVOS Medical Specialities
  • BOF Packaged Foods
  • Sector
  • VVOS Health Care
  • BOF Consumer Staples
  • Exchange
  • VVOS Nasdaq
  • BOF Nasdaq
  • Market Cap
  • VVOS 18.5M
  • BOF 16.7M
  • IPO Year
  • VVOS 2020
  • BOF 2023
  • Fundamental
  • Price
  • VVOS $2.57
  • BOF $2.41
  • Analyst Decision
  • VVOS Strong Buy
  • BOF
  • Analyst Count
  • VVOS 2
  • BOF 0
  • Target Price
  • VVOS $6.30
  • BOF N/A
  • AVG Volume (30 Days)
  • VVOS 79.1K
  • BOF 185.5K
  • Earning Date
  • VVOS 03-31-2025
  • BOF 05-13-2025
  • Dividend Yield
  • VVOS N/A
  • BOF N/A
  • EPS Growth
  • VVOS N/A
  • BOF N/A
  • EPS
  • VVOS N/A
  • BOF N/A
  • Revenue
  • VVOS $15,031,000.00
  • BOF $6,489,951.00
  • Revenue This Year
  • VVOS $12.35
  • BOF N/A
  • Revenue Next Year
  • VVOS $26.02
  • BOF N/A
  • P/E Ratio
  • VVOS N/A
  • BOF N/A
  • Revenue Growth
  • VVOS 8.91
  • BOF 372.36
  • 52 Week Low
  • VVOS $1.91
  • BOF $0.61
  • 52 Week High
  • VVOS $6.28
  • BOF $4.11
  • Technical
  • Relative Strength Index (RSI)
  • VVOS 30.17
  • BOF 57.91
  • Support Level
  • VVOS $3.45
  • BOF $2.09
  • Resistance Level
  • VVOS $3.36
  • BOF $2.82
  • Average True Range (ATR)
  • VVOS 0.30
  • BOF 0.23
  • MACD
  • VVOS -0.08
  • BOF 0.04
  • Stochastic Oscillator
  • VVOS 13.24
  • BOF 59.80

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About BOF BranchOut Food Inc.

Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are primarily located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.

Share on Social Networks: